shCCL20 Citations (1)

Originally described in: CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis.
Affo S, Morales-Ibanez O, Rodrigo-Torres D, Altamirano J, Blaya D, Dapito DH, Millan C, Coll M, Caviglia JM, Arroyo V, Caballeria J, Schwabe RF, Gines P, Bataller R, Sancho-Bru P Gut. 2014 Nov;63(11):1782-92. doi: 10.1136/gutjnl-2013-306098. Epub 2014 Jan 10. PubMed Journal

---

Articles Citing shCCL20

Articles
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses. Bruchard M, Geindreau M, Perrichet A, Truntzer C, Ballot E, Boidot R, Racoeur C, Barsac E, Chalmin F, Hibos C, Baranek T, Paget C, Ryffel B, Rebe C, Paul C, Vegran F, Ghiringhelli F. Nat Immunol. 2022 Feb;23(2):262-274. doi: 10.1038/s41590-021-01120-y. Epub 2022 Jan 31. PubMed

If you have published an article using this material, please email us at to have your article added to this page.